WO2008068408A2 - Oral hygiene composition and its use in the treatment of halitosis - Google Patents

Oral hygiene composition and its use in the treatment of halitosis Download PDF

Info

Publication number
WO2008068408A2
WO2008068408A2 PCT/FR2007/001849 FR2007001849W WO2008068408A2 WO 2008068408 A2 WO2008068408 A2 WO 2008068408A2 FR 2007001849 W FR2007001849 W FR 2007001849W WO 2008068408 A2 WO2008068408 A2 WO 2008068408A2
Authority
WO
WIPO (PCT)
Prior art keywords
composition
essential oil
green tea
tea extract
parsley
Prior art date
Application number
PCT/FR2007/001849
Other languages
French (fr)
Other versions
WO2008068408A3 (en
WO2008068408A9 (en
Inventor
Jean-Claude Vezin
Gérard D'ARROS
Original Assignee
Pierre Fabre Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament filed Critical Pierre Fabre Medicament
Publication of WO2008068408A2 publication Critical patent/WO2008068408A2/en
Publication of WO2008068408A3 publication Critical patent/WO2008068408A3/en
Publication of WO2008068408A9 publication Critical patent/WO2008068408A9/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/82Theaceae (Tea family), e.g. camellia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Definitions

  • the present invention relates to a composition based on parsley essential oil and a green tea extract as well as its use in nutraceutical, cosmetic and / or therapeutic preparations for the preparation of a medicament for preventing and / or treat halitosis.
  • halitosis The main origin of halitosis is oral in about 85% of cases, ENT problems, digestive are the cause of 10% of cases, halitosis can also be a consequence of diseases such as diabetes or certain cancers .
  • the main cause of the oral origin is bacterial.
  • Certain bacteria such as Porphyromonas, Prevotella, Fusobacterium present on the dental surfaces, in the periodontal pockets, on the dorsal part of the tongue, in the presence of food debris of amino acids, and as a function of the pH release volatile compounds dragged towards the outside by the exhaled air.
  • menthol flavors transiently masks bad smells, but this action is fleeting and the extreme sensitivity of people makes this concept random.
  • Another method may be useful and effective, it consists of using molecules or complex extracts reacting with the sulfur compounds mentioned above to make them less or nonvolatile. These are essentially zinc salts, especially chlorides or lactates, green tea extracts and some essential oils.
  • the present invention relates to an oral hygiene composition
  • an oral hygiene composition comprising a combination of parsley essential oil and a green tea extract; and its use in nutraceutical, cosmetic and / or therapeutic preparations for the preparation of a medicament for preventing and / or treating oral diseases including halitosis.
  • the oral hygiene composition according to the present invention comprising parsley essential oil and a green tea extract is characterized in that the amounts of essential oil of parsley and green tea extract are respectively between 0.01 and 5%; and between 0.005 and 1% by weight relative to the total weight of the composition.
  • parsley essential oil is intended to mean the essential oil obtained from leaves and / or stalks of parsley.
  • the amounts of green tea extract in the composition are expressed by weight of dry extract of green tea relative to the total weight of said composition.
  • the amount of parsley essential oil is between 0.02 and 2% and even more preferably between 0.1 and 1% by weight relative to the total weight of the composition.
  • the amount of green tea extract is between 0.008 and 0.5% and even more advantageously between 0.01 and 0.1% by weight relative to the total weight of the composition.
  • the anti-halitosis composition according to the present invention is particularly effective when the mass ratio essential oil of parsley / green tea extract is between 5 and 30, preferentially between 10 and 20 and even more preferentially about equal. at 15. It has been remarked surprisingly and completely unexpectedly that said composition provides long-term protection.
  • said composition has a pleasant taste accompanied by a feeling of freshness for the end user.
  • composition according to the present invention in the treatment of halitosis was tested in vitro: the various mixtures were brought into contact with sulfur products such as dimethyl mercaptan and the evolution of the concentration of these products. was measured by gas chromatography.
  • the protocol is as follows: In air-filled gas sampling bags equipped with a septum, parsley essential oil and green tea extract were dissolved in alcoholic or hydroalcoholic solution, then dimethyl mercaptan a been introduced. This contact plant extract / dimethyl mercaptan was carried out for a period of 2 minutes before analysis by gas chromatography of the dimethyl mercaptan concentration.
  • the analysis consists in measuring the height of the dimethylmercaptan peak obtained on the chromatogram.
  • the decrease in the height of the dimethylmercaptan peak is characteristic of the efficacy of the extracts in the treatment of halitosis.
  • the most effective mixtures are therefore those having quantities of parsley essential oil and green tea extract of approximately 0.6% and 0.04% respectively; a mass ratio essential oil of parsley / tea extract approximately equal to 15.
  • composition according to the present invention may be in a form selected from the group consisting of a tablet or lozenge (simple or cooked sugar type), capsule, chewing gum, toothpaste, toothpaste gel, mouthwash, spray.
  • a tablet or lozenge simple or cooked sugar type
  • the different excipients to be incorporated into the composition as a function of the dosage form chosen are known to those skilled in the art.
  • the amounts of the active ingredients and excipients will be adjusted by those skilled in the art to obtain a preparation final having a satisfactory taste and texture for the user.
  • the capsule form comprises an envelope which solubilizes very rapidly according to the teaching of the patent application WO03 / 045166.
  • the compressed form to be sucked is of the "cooked sugar" type conventionally known to a person skilled in the art or obtained according to the teaching of application WO02 / 085334.
  • the pellets called cooked sugars are conventionally prepared from a syrup of diluent substance, sweetened or not, boiled, then baked at a higher temperature, typically from 100 0 C to 160 0 C.
  • auxiliary substances such as sweeteners, antioxidants, dyes, flavors and the active ingredient (s).
  • the active ingredient (s) are added to the mass in a mixer as well as auxiliary substances such as sweeteners, anti-oxidants, colorants, flavorings.
  • auxiliary substances such as sweeteners, anti-oxidants, colorants, flavorings.
  • said composition further comprises at least one glycerol ester of a linear C6 to C12 saturated fatty acid.
  • the invention therefore also relates to an anti-halitosis composition
  • an anti-halitosis composition comprising parsley essential oil and a green tea extract in previously described ranges; and at least one glycerol ester of a C6 to C12 linear saturated fatty acid.
  • said glycerol ester is chosen from the group consisting of glycerol esters of fatty acids saturated linear C8 and ClO, used alone or in mixture.
  • composition according to the present invention is the following:
  • COMPOUNDS compared to the total weight of the composition essential oil of parsley 0.1 - 1.0% green tea extract 0.01 - 0.1% glycerol esters of fatty acids C8 and ClO 50 - 80%
  • composition according to the present invention is as follows:
  • COMPOUNDS compared to the total weight of the composition parsley essential oil about 0.6 green tea extract about 0.04 glycerol esters of fatty acids C8 and ClO 50 - 80%
  • Spherical capsules consist of a gelatin shell containing about 0.04% green tea extract; and a liquid core containing about 0.6% parsley essential oil and about 70% glycerol esters of C8 and C10 acids. The percentages shown are grams per 100 grams of final composition.
  • the capsules have a diameter of 4 to 8 mm and a weight of 60 to 160 mg. Conventional excipients used by a person skilled in the art can then be added.
  • the process for producing pellets according to the invention comprises the following steps: a dissolution / boiling step: in a PAGES ® type dissolver, a mixture of purified water and isomalt is heated to boiling. (mass ratio isomalt / water is approximately equal to 5) a cooking step: said mixture is transferred to a cooker type PAGES ® . The mass is cooked until reaching a temperature of about 150 ° C.
  • a mixing step the mass thus recovered is introduced into a previously lubricated type blender RUFFINATI ® where are then added the active ingredients (about 0.6% parsley essential oil and about 0.04% green tea extract ,% by weight of the total weight of the composition)
  • a final step of hot manufacture of the pellets the preparation obtained above is kneaded in a kneader equipped with an internal cooling system type RUFFINATTI. Then the mass is rolled, spun and finally shaped square by pressing. The pellets obtained have a weight of 2.5 g.
  • the pellets are prepared by first making a paste with a portion of sucrose. This dough is heated until slightly boiling. The rest of the sucrose, the active ingredient (s) and the auxiliary substances are then added. After homogenization, the mass thus prepared is dropped dropwise on a cold plate or is injected into a suitable mold.
  • the mucoadhesive fluid gel is composed of an anhydrous base formulated from a vegetable oil and a suspension of hydrophilic polymers.
  • the mixture of active ingredients as described in Example 1 is incorporated in this base.
  • the polymer particles in contact with the saliva hydrate and cause bioadhesion to the mucosa, teeth and tongue, depositing the active ingredients.
  • Example 1 The composition according to Example 1 was tested in vivo. Measurements of concentrations of derivatives in exhaled air are carried out using a halimeter: an instrument that measures the concentration of sulphide molecules in the breath or saliva. The concentration of volatile sulfur compounds is expressed in ppb (part per billion).
  • the literature indicates the ranges of values corresponding to the perception of halitosis by the environment.
  • the apparatus was therefore calibrated using a permeation calibrator PPA200M for hydrogen sulfide.
  • the halimeter is energized for preheating for 6 minutes. The device is then ready to perform the measurements. The user must inhale when the "inhale” signal appears, then the "exhale” signal must blow into the cell containing the detector. A value between 1 and 5 will be displayed on the screen. Twelve volunteers agreed to eat garlic-flavored dishes at lunch and not to brush their teeth afterwards. Two hours later, these people tested their breath using the halimeter described above (measure TO).
  • composition according to the present invention was administered. Two new measurements were taken respectively 15 minutes after taking (measurement at TO + 15 minutes) and 1 hour after (measurement at TO + 1 hour)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to an oral hygiene composition comprising a parsley essential oil composition an a green tea extract, as well as its use in nutraceutic, cosmetic and/or therapeutic compositions for the preparation of a drug for the treatment of halitosis.

Description

COMPOSITION D'HYGIENE BUCCALE ET SON UTILISATION DANS LE TRAITEMENT DE L' HALITOSE ORAL HYGIENE COMPOSITION AND ITS USE IN THE TREATMENT OF HALITOSIS
La présente invention concerne une composition à base d'huile essentielle de persil et d'un extrait de thé vert ainsi que son utilisation dans des préparations nutraceutiques, cosmétiques et/ou thérapeutiques pour la préparation d'un médicament, destinées à prévenir et/ou traiter l'halitose.The present invention relates to a composition based on parsley essential oil and a green tea extract as well as its use in nutraceutical, cosmetic and / or therapeutic preparations for the preparation of a medicament for preventing and / or treat halitosis.
L'origine principale de l'halitose est buccale dans environ 85% des cas, les problèmes ORL, digestifs sont à l'origine de 10% des cas, l'halitose peut également être une conséquence de maladies telles que le diabète ou certains cancers.The main origin of halitosis is oral in about 85% of cases, ENT problems, digestive are the cause of 10% of cases, halitosis can also be a consequence of diseases such as diabetes or certain cancers .
La cause principale de l'origine buccale est bactérienne. Certaines bactéries telles que Porphyromonas, Prevotella, Fusobacterium présentes sur les surfaces dentaires, dans les poches parodontales, sur la partie dorsale de la langue, en présence de débris alimentaires d'acides aminés, et en fonction du pH libèrent des composés volatiles entraînés vers l'extérieur par l'air expiré.The main cause of the oral origin is bacterial. Certain bacteria such as Porphyromonas, Prevotella, Fusobacterium present on the dental surfaces, in the periodontal pockets, on the dorsal part of the tongue, in the presence of food debris of amino acids, and as a function of the pH release volatile compounds dragged towards the outside by the exhaled air.
Ces composés volatiles présentent une odeur forte, très désagréable à des concentrations extrêmement faibles. Ce sont essentiellement des dérivés soufrés et des dérivés aminés. Parmi les dérivés soufrés sont présents essentiellement : l'hydrogène sulfuré H2S le methylmercaptan CH3SH - le dimethylmercaptan (CH3) 2SThese volatile compounds have a strong odor, very unpleasant at extremely low concentrations. These are essentially sulfur derivatives and amino derivatives. Among the sulfur derivatives are present essentially: hydrogen sulfide H 2 S methylmercaptan CH 3 SH - dimethylmercaptan (CH 3 ) 2 S
Ils sont détectables par un « nez humain » dès la concentration de quelques dizaines de ppb. La cause principale de l'halitose étant bien connue, il peut paraître simple de la combattre. On peut imaginer que le renforcement de l'hygiène est un remède efficace. L'utilisation d'antiseptiques réputés actifs dans le domaine bucco-dentaire devrait permettre d'éradiquer les bactéries responsables, mais leur localisation et leur faculté de colonisation et de croissance s'opposent à cette finalité . L'utilisation de solutions antiseptiques améliore l'état pathologique mais n'élimine pas totalement les causes.They are detectable by a "human nose" from the concentration of a few tens of ppb. The main cause of halitosis being well known, it may seem simple to fight it. One can imagine that strengthening hygiene is an effective remedy. The use of antiseptics known to be active in the oral field should make it possible to eradicate the responsible bacteria, but their location and their ability to colonize and grow oppose this purpose. The use of antiseptic solutions improves the disease state but does not completely eliminate the causes.
L'utilisation d'arômes mentholés masque transitoirement les mauvaises odeurs, mais cette action est fugace et l'extrême sensibilité olfactive des personnes rend ce concept aléatoire . Une autre méthode peut s'avérer utile et efficace, elle consiste à utiliser des molécules ou des extraits complexes réagissant avec les composés soufrés cités précédemment pour les rendre moins ou non volatiles. Ce sont essentiellement des sels de zinc, notamment des chlorures ou des lactates, des extraits de thé vert et certaines huiles essentielles.The use of menthol flavors transiently masks bad smells, but this action is fleeting and the extreme sensitivity of people makes this concept random. Another method may be useful and effective, it consists of using molecules or complex extracts reacting with the sulfur compounds mentioned above to make them less or nonvolatile. These are essentially zinc salts, especially chlorides or lactates, green tea extracts and some essential oils.
Par conséquent, il apparaît nécessaire de disposer d'une nouvelle composition anti-halitose dont l'efficacité serait renforcée par rapport aux compositions de l'art antérieur.Therefore, it appears necessary to have a new anti-halitosis composition whose effectiveness would be enhanced compared to the compositions of the prior art.
A cette fin, la présente invention concerne une composition d'hygiène buccale comprenant une association d'huile essentielle de persil et un extrait de thé vert ; et son utilisation dans des préparations nutraceutiques , cosmétiques et/ou thérapeutiques pour la préparation d'un médicament, destinées à prévenir et/ou traiter des maladies bucco-dentaires dont l'halitose. Avantageusement, la composition d'hygiène buccale selon la présente invention comprenant de l'huile essentielle de persil et un extrait de thé vert est caractérisée en ce que les quantités d'huile essentielle de persil et d'extrait de thé vert sont respectivement comprises entre 0,01 et 5 % ; et entre 0,005 et 1 % en poids par rapport au poids total de la composition.To this end, the present invention relates to an oral hygiene composition comprising a combination of parsley essential oil and a green tea extract; and its use in nutraceutical, cosmetic and / or therapeutic preparations for the preparation of a medicament for preventing and / or treating oral diseases including halitosis. Advantageously, the oral hygiene composition according to the present invention comprising parsley essential oil and a green tea extract is characterized in that the amounts of essential oil of parsley and green tea extract are respectively between 0.01 and 5%; and between 0.005 and 1% by weight relative to the total weight of the composition.
Par « huile essentielle de persil », il faut entendre au sens de la présente invention l'huile essentielle obtenue à partir de feuilles et/ou de tiges de persil.For the purposes of the present invention, the term "parsley essential oil" is intended to mean the essential oil obtained from leaves and / or stalks of parsley.
Au sens de la présente invention, les quantités d'extrait de thé vert dans la composition sont exprimées en poids d'extrait sec de thé vert par rapport au poids total de ladite composition.For the purposes of the present invention, the amounts of green tea extract in the composition are expressed by weight of dry extract of green tea relative to the total weight of said composition.
Préfèrentiellement, la quantité d'huile essentielle de persil est comprise entre 0,02 et 2 % et encore plus préférentiellement comprise entre 0,1 et 1 % en poids par rapport au poids total de la composition.Preferentially, the amount of parsley essential oil is between 0.02 and 2% and even more preferably between 0.1 and 1% by weight relative to the total weight of the composition.
Avantageusement, la quantité d'extrait de thé vert est comprise entre 0,008 et 0,5 % et encore plus avantageusement comprise entre 0,01 et 0,1 % en poids par rapport au poids total de la composition.Advantageously, the amount of green tea extract is between 0.008 and 0.5% and even more advantageously between 0.01 and 0.1% by weight relative to the total weight of the composition.
La demanderesse a montré en outre que la composition anti- halitose selon la présente invention est particulièrement efficace lorsque le ratio massique huile essentielle de persil / extrait de thé vert est compris entre 5 et 30, préférentiellement entre 10 et 20 et encore plus préférentiellement environ égal à 15. II a été remarqué, et ceci de manière surprenante et complètement inattendue que ladite composition assure une protection longue durée.The Applicant has furthermore shown that the anti-halitosis composition according to the present invention is particularly effective when the mass ratio essential oil of parsley / green tea extract is between 5 and 30, preferentially between 10 and 20 and even more preferentially about equal. at 15. It has been remarked surprisingly and completely unexpectedly that said composition provides long-term protection.
De même, ladite composition présente un goût agréable accompagné d'une sensation de fraîcheur pour l'utilisateur final .Similarly, said composition has a pleasant taste accompanied by a feeling of freshness for the end user.
Rien dans l'état de l'art ne suggérait cette association dans ces gammes particulières afin d'obtenir un effet synergique dans la prévention et/ou le traitement de maladies bucco-dentaires et en particulier de l'halitose.Nothing in the state of the art suggested this combination in these particular ranges in order to obtain a synergistic effect in the prevention and / or treatment of oral diseases and in particular of halitosis.
L'efficacité de la composition selon la présente invention dans le traitement de l'halitose a été testé in vitro : les différents mélanges ont été mis en contact avec des produits soufrés tels que le diméthylmercaptan et l'évolution de la concentration de ces produits a été mesurée par chromatographie en phase gazeuse . Le protocole est le suivant : Dans des sacs pour échantillonage de gaz remplis d'air et équipés d'un septum, l'huile essentielle de persil et l'extrait de thé vert ont été mis en solution alcoolique ou hydroalcoolique, puis le diméthylmercaptan a été introduit. Ce contact extrait de plante / diméthylmercaptan a été réalisé pendant une durée de 2 minutes avant analyse par chromatographie en phase gazeuse de la concentration en diméthylmercaptan .The effectiveness of the composition according to the present invention in the treatment of halitosis was tested in vitro: the various mixtures were brought into contact with sulfur products such as dimethyl mercaptan and the evolution of the concentration of these products. was measured by gas chromatography. The protocol is as follows: In air-filled gas sampling bags equipped with a septum, parsley essential oil and green tea extract were dissolved in alcoholic or hydroalcoholic solution, then dimethyl mercaptan a been introduced. This contact plant extract / dimethyl mercaptan was carried out for a period of 2 minutes before analysis by gas chromatography of the dimethyl mercaptan concentration.
L'analyse consiste en la mesure de la hauteur du pic de diméthylmercaptan obtenu sur le chromatogramme .The analysis consists in measuring the height of the dimethylmercaptan peak obtained on the chromatogram.
Conditions expérimentales : Colonne capillaire apolaire Injection par vanneExperimental conditions: Apolar capillary column Injection by valve
Détecteur TCD en couplage avec un détecteur FID Température : mode isotherme a 1200C. Les résultats obtenus sont présentés dans le tableau 1 ci- dessous :TCD detector in coupling with a FID detector Temperature: isothermal mode at 120 ° C. The results obtained are shown in Table 1 below:
Figure imgf000006_0001
Figure imgf000006_0001
TABLEAU 1 : efficacité de différents mélanges huile essentielle de persil / extrait de thé vert dans le traitement de l'halitoseTABLE 1: Efficacy of different mixtures of parsley essential oil / green tea extract in the treatment of halitosis
La diminution de la hauteur du pic de diméthylmercaptan est caractéristique de l'efficacité des extraits dans le traitement de l'halitose.The decrease in the height of the dimethylmercaptan peak is characteristic of the efficacy of the extracts in the treatment of halitosis.
Les mélanges les plus performants sont donc ceux ayant des quantités d'huile essentielle de persil et d'extrait de thé vert environ égale à 0,6% et 0,04% respectivement ; soit un ratio massique huile essentielle de persil / extrait de thé environ égal a 15.The most effective mixtures are therefore those having quantities of parsley essential oil and green tea extract of approximately 0.6% and 0.04% respectively; a mass ratio essential oil of parsley / tea extract approximately equal to 15.
La composition selon la présente invention peut se présenter sous une forme choisie parmi le groupe constitué d'un comprimé ou pastille (simple ou type sucre cuit), capsule, gomme à mâcher, pâte dentifrice, gel dentifrice, bain de bouche, spray. Les différents excipients à intégrer dans la composition en fonction de la forme galénique retenue sont connus de l'homme du métier. Les quantités des principes actifs et des excipients seront ajustés par l'Homme du métier pour obtenir une préparation finale ayant un goût et une texture satisfaisants pour 1' utilisateur.The composition according to the present invention may be in a form selected from the group consisting of a tablet or lozenge (simple or cooked sugar type), capsule, chewing gum, toothpaste, toothpaste gel, mouthwash, spray. The different excipients to be incorporated into the composition as a function of the dosage form chosen are known to those skilled in the art. The amounts of the active ingredients and excipients will be adjusted by those skilled in the art to obtain a preparation final having a satisfactory taste and texture for the user.
De manière préférée, la forme capsule comprend une enveloppe qui se solubilise très rapidement selon l'enseignement de la demande de brevet WO03/045166.Preferably, the capsule form comprises an envelope which solubilizes very rapidly according to the teaching of the patent application WO03 / 045166.
De façon avantageuse, la forme comprimé à sucer est de type « sucre cuit » connu classiquement de l'Homme du métier ou obtenu selon l'enseignement de la demande WO02/085334. Les pastilles appelées sucres cuits sont classiquement préparées à partir d'un sirop de substance diluante, sucrée ou non, porté à ébullition, puis cuit à température plus élevée, typiquement de 1000C à 1600C. A cette base sucrée, sont ajoutées des substances auxiliaires telles qu' édulcorants, antioxydants, colorants, arômes et le ou les principes actifs.Advantageously, the compressed form to be sucked is of the "cooked sugar" type conventionally known to a person skilled in the art or obtained according to the teaching of application WO02 / 085334. The pellets called cooked sugars are conventionally prepared from a syrup of diluent substance, sweetened or not, boiled, then baked at a higher temperature, typically from 100 0 C to 160 0 C. To this sweet base, are added auxiliary substances such as sweeteners, antioxidants, dyes, flavors and the active ingredient (s).
En fin de cuisson, le ou les principes actifs sont ajoutés à la masse dans un mélangeur ainsi que les substances auxiliaires telles qu' édulcorants, anti-oxydants, colorants, arômes. La masse ainsi préparée est pétrie sur une surface froide appropriée, puis roulée et filée, pour être ensuite pressée ou découpée en pastilles à la forme désirée.At the end of cooking, the active ingredient (s) are added to the mass in a mixer as well as auxiliary substances such as sweeteners, anti-oxidants, colorants, flavorings. The mass thus prepared is kneaded on a suitable cold surface, then rolled and spun, to then be pressed or cut into pellets to the desired shape.
Dans un mode de réalisation particulier de l'invention, ladite composition comprend en outre au moins un ester de glycérol d'un acide gras saturé linéaire en C6 à C12.In a particular embodiment of the invention, said composition further comprises at least one glycerol ester of a linear C6 to C12 saturated fatty acid.
L' invention concerne donc également une composition anti- halitose comprenant de l'huile essentielle de persil et un extrait de thé vert dans des gammes précédemment décrites ; et au moins un ester de glycérol d' un acide gras saturé linéaire en C6 à C12.The invention therefore also relates to an anti-halitosis composition comprising parsley essential oil and a green tea extract in previously described ranges; and at least one glycerol ester of a C6 to C12 linear saturated fatty acid.
Avantageusement, ledit ester de glycérol est choisi parmi le groupe constitué des esters de glycérol d'acides gras saturés linéaires en C8 et en ClO, utilisés seuls ou en mélange .Advantageously, said glycerol ester is chosen from the group consisting of glycerol esters of fatty acids saturated linear C8 and ClO, used alone or in mixture.
Avantageusement, la composition selon la présente invention est la suivante :Advantageously, the composition according to the present invention is the following:
% en poids par% by weight
COMPOSE rapport au poids total de la composition huile essentielle de persil 0,1 - 1,0% extrait de thé vert 0, 01 - 0,1% esters de glycérol d'acides gras C8 et ClO 50 - 80%COMPOUNDS compared to the total weight of the composition essential oil of parsley 0.1 - 1.0% green tea extract 0.01 - 0.1% glycerol esters of fatty acids C8 and ClO 50 - 80%
Gélatine 10%Gelatin 10%
Excipients qs.Excipients qs.
De façon encore plus avantageuse, la composition selon la présente invention est la suivante :Even more advantageously, the composition according to the present invention is as follows:
% en poids par% by weight
COMPOSE rapport au poids total de la composition huile essentielle de persil environ 0 , 6 extrait de thé vert environ 0,04 esters de glycérol d'acides gras C8 et ClO 50 - 80%COMPOUNDS compared to the total weight of the composition parsley essential oil about 0.6 green tea extract about 0.04 glycerol esters of fatty acids C8 and ClO 50 - 80%
Gélatine 10%Gelatin 10%
Excipients qs. EXEMPLES DE FORMULATION :Excipients qs. EXAMPLES OF FORMULATION:
EXEMPLE 1 : capsule à dissolution instantanéeEXAMPLE 1 Instant Dissolving Capsule
Des capsules de forme sphérique sont constituées d'une enveloppe de gélatine contenant environ 0,04 % d'extrait de thé vert ; et d'un noyau liquide contenant environ 0,6 % d'huile essentielle de persil et 70% environ d'esters de glycérol des acides en C8 et en ClO . Les pourcentages indiqués représentent des grammes pour 100 grammes de composition finale.Spherical capsules consist of a gelatin shell containing about 0.04% green tea extract; and a liquid core containing about 0.6% parsley essential oil and about 70% glycerol esters of C8 and C10 acids. The percentages shown are grams per 100 grams of final composition.
Les capsules ont un diamètre de 4 à 8 mm pour un poids de 60 à 160 mg . Des excipients classiques utilisés par un homme du métier peuvent ensuite être ajoutés.The capsules have a diameter of 4 to 8 mm and a weight of 60 to 160 mg. Conventional excipients used by a person skilled in the art can then be added.
EXEMPLE 2 : pastille à sucerEXAMPLE 2: lozenge to suck
Le procédé de fabrication de pastilles selon l'invention comprend les étapes suivantes : - une étape de dissolution / ébullition : dans un dissolveur type PAGES®, un mélange d'eau purifiée et d' isomalt est chauffé jusqu'à ébullition. (ratio massique isomalt /eau est environ égal à 5) une étape de cuisson : ledit mélange est transféré jusqu'à un cuiseur type PAGES®. La masse est lors cuite jusqu'à atteindre une température de l'ordre de 15O0C environ. une étape de mélange : la masse ainsi récupérée est introduite dans un mélangeur type RUFFINATI® préalablement lubrifié où sont alors ajoutés les principes actifs (environ 0,6% d'huile essentielle de persil et environ 0,04% d'extrait de thé vert, % en poids du poids total de la composition) une dernière étape de fabrication à chaud des pastilles: la préparation obtenue précédemment est pétrie dans un pétrisseur équipé d'un système interne de refroidissement type RUFFINATTI . Puis la masse est roulée, filée et enfin mise en forme carrée par pressage. Les pastilles obtenues ont un poids de 2,5g.The process for producing pellets according to the invention comprises the following steps: a dissolution / boiling step: in a PAGES ® type dissolver, a mixture of purified water and isomalt is heated to boiling. (mass ratio isomalt / water is approximately equal to 5) a cooking step: said mixture is transferred to a cooker type PAGES ® . The mass is cooked until reaching a temperature of about 150 ° C. a mixing step: the mass thus recovered is introduced into a previously lubricated type blender RUFFINATI ® where are then added the active ingredients (about 0.6% parsley essential oil and about 0.04% green tea extract ,% by weight of the total weight of the composition) a final step of hot manufacture of the pellets: the preparation obtained above is kneaded in a kneader equipped with an internal cooling system type RUFFINATTI. Then the mass is rolled, spun and finally shaped square by pressing. The pellets obtained have a weight of 2.5 g.
Les pastilles sont préparées en réalisant d'abord une pâte avec une partie de saccharose. Cette pâte est chauffée jusqu'à légère ébullition. Le reste du saccharose, le ou les principes actifs ainsi que les substances auxiliaires sont alors ajoutés. Après homogénéisation, on fait tomber la masse ainsi préparée goutte à goutte sur une plaque froide ou on l'irrjecte dans un moule approprié.The pellets are prepared by first making a paste with a portion of sucrose. This dough is heated until slightly boiling. The rest of the sucrose, the active ingredient (s) and the auxiliary substances are then added. After homogenization, the mass thus prepared is dropped dropwise on a cold plate or is injected into a suitable mold.
La fabrication de ces pastilles est réalisée à chaud.The manufacture of these pellets is carried out hot.
L'indication « sans sucre » sera utilisée dans le cas où la composition ne contiendra pas de saccharose.The indication "without sugar" will be used in the case where the composition will not contain sucrose.
EXEMPLE 3 : gel fluide mucoadhésifEXAMPLE 3 mucoadhesive fluid gel
Le gel fluide mucoadhésif est composé d'une base anhydre formulée à partir d'une huile végétale et d'une suspension de polymères hydrophiles. Le mélange d'actifs tel que décrit dans l'exemple 1 est incorporé dans cette base. Les particules de polymère au contact de la salive s'hydratent et provoquent une bioadhésion à la muqueuse, aux dents et à la langue, y déposant les actifs. EVALUATION IN VIVO :The mucoadhesive fluid gel is composed of an anhydrous base formulated from a vegetable oil and a suspension of hydrophilic polymers. The mixture of active ingredients as described in Example 1 is incorporated in this base. The polymer particles in contact with the saliva hydrate and cause bioadhesion to the mucosa, teeth and tongue, depositing the active ingredients. EVALUATION IN VIVO:
La composition selon l'exemple 1 a été testée m vivo. Les mesures de concentrations de dérivés dans l'air expiré sont réalisées à l'aide d'un halimètre: instrument qui mesure la concentration de molécules de sulfure dans l'haleine ou la salive. La concentration en composés sulfurés volatiles est exprimée en ppb (part per billion) .The composition according to Example 1 was tested in vivo. Measurements of concentrations of derivatives in exhaled air are carried out using a halimeter: an instrument that measures the concentration of sulphide molecules in the breath or saliva. The concentration of volatile sulfur compounds is expressed in ppb (part per billion).
La littérature indique les plages de valeurs correspondant à la perception de l'halitose par l'environnement.The literature indicates the ranges of values corresponding to the perception of halitosis by the environment.
L'appareil a donc été étalonné à l'aide d'un calibreur à perméation PPA200M pour l'hydrogène sulfuré.The apparatus was therefore calibrated using a permeation calibrator PPA200M for hydrogen sulfide.
Cinq plages de mesures notées de 1 à 5 ont été définies pour la concentration en dérivés soufrés :Five measurement ranges from 1 to 5 were defined for the concentration of sulfur derivatives:
Concentration en dérivés soufrés (ppb) indiceConcentration of sulfur derivatives (ppb) index
< 150 ppb 1<150 ppb 1
De 150 à 300 ppb 2From 150 to 300 ppb 2
De 300 à 450 ppb 3From 300 to 450 ppb 3
De 450 à 600 ppb 4From 450 to 600 ppb 4
> 600 ppb 5> 600 ppb 5
L'utilisation de l' halimètre est très simple : l' halimètre est mis sous tension pour préchauffage pendant 6 minutes. L'appareil est ensuite prêt pour effectuer les mesures. L'utilisateur doit inspirer lorsque le signal « inspirez » apparaît , puis au signal « expirer » doit souffler dans la cellule contenant le détecteur. Une valeur comprise entre 1 et 5 s'affiche alors sur l'écran. Douze volontaires ont accepté de consommer lors du déjeuner des mets aromatisés à l'ail et de ne pas se brosser les dents ensuite. Deux heures plus tard, ces personnes testaient leur haleine à l'aide de l'halimètre décrit précédemment (mesure à TO) .The use of the halimeter is very simple: the halimeter is energized for preheating for 6 minutes. The device is then ready to perform the measurements. The user must inhale when the "inhale" signal appears, then the "exhale" signal must blow into the cell containing the detector. A value between 1 and 5 will be displayed on the screen. Twelve volunteers agreed to eat garlic-flavored dishes at lunch and not to brush their teeth afterwards. Two hours later, these people tested their breath using the halimeter described above (measure TO).
Puis une composition selon la présente invention a été administrée. Deux nouvelles mesures ont été réalisées respectivement 15 minutes après la prise (mesure à TO + 15 minutes) et 1 heure après (mesure à TO + lheure)Then a composition according to the present invention was administered. Two new measurements were taken respectively 15 minutes after taking (measurement at TO + 15 minutes) and 1 hour after (measurement at TO + 1 hour)
Les résultats obtenus sont présentés dans le tableau 2 ci- dessous :The results obtained are shown in Table 2 below:
Figure imgf000012_0001
Figure imgf000012_0001
TABLEAU 2 évaluation m vivo d'une composition selon l'exemple 1 dans le traitement de l'halitoseTABLE 2 • In Vivo Evaluation of a Composition According to Example 1 in the Treatment of Halitosis
Les résultats obtenus montrent une diminution significative des valeurs de l'halitose après utilisation de la composition décrite. The results obtained show a significant decrease in the values of halitosis after use of the described composition.

Claims

REVENDICATIONS
1. Utilisation d'une composition d'hygiène buccale comprenant de l'huile essentielle de persil et un extrait de thé vert caractérisée en ce que les quantités d'huile essentielle de persil et d'extrait de thé vert sont respectivement comprises entre 0,01 et 5 % ; et entre 0,005 et 1 % en poids par rapport au poids total de la composition, dans des préparations nutraceutiques , cosmétiques et/ou thérapeutiques pour la préparation d'un médicament, destinées à prévenir et/ou traiter l'halitose. 1. Use of an oral hygiene composition comprising parsley essential oil and a green tea extract characterized in that the amounts of parsley essential oil and green tea extract are respectively between 0, 01 and 5%; and between 0.005 and 1% by weight relative to the total weight of the composition, in nutraceutical, cosmetic and / or therapeutic preparations for the preparation of a medicament for preventing and / or treating halitosis.
2. Utilisation selon la revendication 1 caractérisée en ce que le ratio massique huile essentielle de persil / extrait de thé vert est compris entre 5 et 30.2. Use according to claim 1 characterized in that the mass ratio essential oil of parsley / green tea extract is between 5 and 30.
3. Utilisation selon la revendication 1 ou 2 caractérisée en ce que le ratio massique huile essentielle de persil / extrait de thé vert est égal à 15.3. Use according to claim 1 or 2 characterized in that the mass ratio essential oil of parsley / green tea extract is equal to 15.
4. Utilisation selon l'une quelconque des revendications précédentes caractérisée en ce que la quantité d'huile essentielle de persil est égale à 0,6% en poids par rapport au poids total de la composition. 4. Use according to any one of the preceding claims characterized in that the amount of parsley essential oil is equal to 0.6% by weight relative to the total weight of the composition.
5. Utilisation selon l'une quelconque des revendications précédentes caractérisée en ce que la quantité d'extrait de thé vert est égale à 0,04% en poids par rapport au poids total de la composition.5. Use according to any one of the preceding claims characterized in that the amount of green tea extract is equal to 0.04% by weight relative to the total weight of the composition.
6. Utilisation selon l'une quelconque des revendications précédentes caractérisée en ce qu'elle contient en outre au moins un ester de glycérol d'un acide gras saturé linéaire en C6 à C12.6. Use according to any one of the preceding claims characterized in that it further contains at least one glycerol ester of a linear saturated fatty acid C6 to C12.
7. Utilisation selon l'une quelconque des revendications précédentes caractérisée en ce que ledit ester de glycérol est choisi parmi le groupe constitué des esters de glycérol d'acides gras saturés linéaires en7. Use according to any one of the preceding claims characterized in that said ester of glycerol is selected from the group consisting of glycerol esters of linear saturated fatty acids in
C8 et en ClO, utilisés seuls ou en mélanges.C8 and ClO, used alone or in mixtures.
8. Utilisation selon l'une quelconque des revendications précédentes caractérisée en ce qu'elle comprend de8. Use according to any one of the preceding claims, characterized in that it comprises
0,1 à 1,0% d'huile essentielle de persil ; de 0,01 à0.1 to 1.0% parsley essential oil; from 0.01 to
0,1% d'extrait de thé vert ; de 50 à 80% d'esters de glycérol d'acides gras C8 et ClO ; environ 10% de gélatine et des excipients en quantité suffisante ; les pourcentages étant indiqués en poids par rapport au poids total de la composition. 0.1% green tea extract; from 50 to 80% of glycerol esters of C8 and ClO fatty acids; about 10% gelatin and sufficient excipients; the percentages being indicated by weight relative to the total weight of the composition.
PCT/FR2007/001849 2006-11-13 2007-11-08 Oral hygiene composition and its use in the treatment of halitosis WO2008068408A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0609916 2006-11-13
FR0609916A FR2908311B1 (en) 2006-11-13 2006-11-13 ORAL HYGIENE COMPOSITION AND ITS USE IN THE TREATMENT OF HALITOSIS

Publications (3)

Publication Number Publication Date
WO2008068408A2 true WO2008068408A2 (en) 2008-06-12
WO2008068408A3 WO2008068408A3 (en) 2008-07-24
WO2008068408A9 WO2008068408A9 (en) 2009-08-13

Family

ID=38123924

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/001849 WO2008068408A2 (en) 2006-11-13 2007-11-08 Oral hygiene composition and its use in the treatment of halitosis

Country Status (2)

Country Link
FR (1) FR2908311B1 (en)
WO (1) WO2008068408A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013167742A1 (en) 2012-05-11 2013-11-14 Pierre Fabre Medicament Rapidly disintegrating monolayer film and use thereof in oral hygiene

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102846791A (en) * 2012-09-03 2013-01-02 南通博大生化有限公司 Halitosis removing bactericide

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020054859A1 (en) * 1998-02-06 2002-05-09 Biocosmetic, S.L. Composition for the treatment of halitosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0253717A (en) * 1988-08-18 1990-02-22 Momotani Jiyuntenkan:Kk Dentifrice or mouth wash
JP2588031B2 (en) * 1989-08-21 1997-03-05 太陽化学株式会社 Mouthwash containing tea polyphenol compound
JP3535575B2 (en) * 1994-07-26 2004-06-07 三井農林株式会社 Anti-caries agent
JPH10263064A (en) * 1997-03-25 1998-10-06 Eco Sci:Kk Deodorant

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020054859A1 (en) * 1998-02-06 2002-05-09 Biocosmetic, S.L. Composition for the treatment of halitosis

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
BRADSHAW D J ET AL: "Creation of oral care flavours to deliver breath-freshening benefits" ORAL DISEASES 2005 DENMARK, vol. 11, no. SUPPL. 1, 2005, pages 75-79, XP002438199 ISSN: 1354-523X 1601-0825 *
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 2003, SCHIFFENBAUER M ET AL: "The antimicrobial effect of green tea and polyphenol." XP002438201 Database accession no. PREV200300546613 & ABSTRACTS OF THE GENERAL MEETING OF THE AMERICAN SOCIETY FOR MICROBIOLOGY, vol. 103, 2003, pages Q-228 URL, 103RD AMERICAN SOCIETY FOR MICROBIOLOGY GENERAL MEETING; WASHINGTON, DC, USA; MAY 18-22, 2003 ISSN: 1060-2011 *
DATABASE EMBASE [Online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; 1998, TSUCHIYA H ET AL: "Retention of green tea catechins in oral cavity (1) - Salivary concentrations of catechins after mouthrinsing" XP002438202 Database accession no. EMB-1999069050 & ORAL THERAPEUTICS AND PHARMACOLOGY 1998 JAPAN, vol. 17, no. 3, 1998, pages 138-146, ISSN: 0288-1012 *
DATABASE WPI Week 199014 Derwent Publications Ltd., London, GB; AN 1990-103151 XP002438208 & JP 02 053717 A (MOMOYA JUNTENKAN KK) 22 février 1990 (1990-02-22) *
DATABASE WPI Week 199120 Derwent Publications Ltd., London, GB; AN 1991-143147 XP002438209 & JP 03 077817 A (TAIYO KAGAKU KK) 3 avril 1991 (1991-04-03) *
DATABASE WPI Week 199615 Derwent Publications Ltd., London, GB; AN 1996-146888 XP002438210 & JP 08 034743 A (MITSUI NORIN KK) 6 février 1996 (1996-02-06) *
DATABASE WPI Week 199850 Derwent Publications Ltd., London, GB; AN 1998-587630 XP002438207 & JP 10 263064 A (ECOSCIENCE KK) 6 octobre 1998 (1998-10-06) *
MAKIMURA M ET AL: "INHIBITORY EFFECT OF THEA CATECHINS ON COLLAGNENASE ACTIVITY" JOURNAL OF PERIODONTOLOGY, AMERICAN ACADEMY OF PERIODONTOLOGY, CHICAGO, IL, US, vol. 64, no. 7, 1993, pages 630-636, XP001010466 ISSN: 0022-3492 *
PATEL V K ET AL: "Folklore therapeutic indigenous plants in periodontal disorders in India (review, experimental and clinical approach)" INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY THERAPY AND TOXICOLOGY 1988 GERMANY, vol. 26, no. 4, 1988, pages 176-184, XP008080162 ISSN: 0174-4879 *
SAKANAKA SENJI ET AL: "Inhibitory effects of green tea polyphenols on the production of a virulence factor of the periodontal-disease-causing anaerobic bacterium Porphyromonas gingivalis." JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 52, no. 6, 24 mars 2004 (2004-03-24), pages 1688-1692, XP002438200 ISSN: 0021-8561 *
WOLINSKY LAWRENCE E ET AL: "A comparative pilot study of the effects of a dentifrice containing green tea bioflavonoids, sanguinarine or triclosan on oral bacterial biofilm formation" JOURNAL OF CLINICAL DENTISTRY, vol. 11, no. 2, 2000, pages 53-58, XP008080165 ISSN: 0895-8831 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013167742A1 (en) 2012-05-11 2013-11-14 Pierre Fabre Medicament Rapidly disintegrating monolayer film and use thereof in oral hygiene
FR2990349A1 (en) * 2012-05-11 2013-11-15 Pf Medicament FAST DISINTEGRATING MONOLAYER FILM AND ITS USE IN ORAL HYGIENE

Also Published As

Publication number Publication date
FR2908311A1 (en) 2008-05-16
FR2908311B1 (en) 2010-02-26
WO2008068408A3 (en) 2008-07-24
WO2008068408A9 (en) 2009-08-13

Similar Documents

Publication Publication Date Title
CA2470464C (en) Use of heliopsis longipes extract in oral compositions
JP2001527540A (en) Confectionery composition
FR2931071A1 (en) ALGAE CONFECTIONERY FOR THE PREVENTION OF ORAL INFECTIONS
Lif Holgerson et al. Xylitol concentration in saliva and dental plaque after use of various xylitol-containing products
JP7413465B2 (en) Composition for preventing or treating oral diseases
WO2008068408A2 (en) Oral hygiene composition and its use in the treatment of halitosis
KR102700606B1 (en) Composition for prevention or treatment of oral disease comprising icaritin
EP3043783A1 (en) Lubricating complex for the mouth
KR102665310B1 (en) Composition for prevention or treatment of oral disease comprising Verbascoside
RU2618889C1 (en) Mouthwash agent having antiinflammatory, antimicrobial, wound-healing effect
KR100797975B1 (en) Oral compositions against halitosis
JP2015166328A (en) Chewable tablet
US20160346171A1 (en) Oral composition and confection
CN114931518B (en) Chinese gall astringency masking agent and application thereof
JP7321632B2 (en) Composition for prevention or treatment of oral disease
EP0910341B1 (en) Pharmaceutical composition to be administered orally
JP7394295B2 (en) Candy formulation and method for manufacturing candy formulation
JP2009286749A (en) Solid material for oral cavity hygiene
EP1786405B1 (en) Use and compounds for perceiving or controlling alcool intake
KR20180047705A (en) Composition for prevention or treatment of oral disease comprising Forsythiae Fructus extract
CH718673A1 (en) Oral care compositions.
WO2005018655A1 (en) Use of noni in relation to oral pathologies, for example, in order to combat problems associated with asialia and hyposialia
KR20180046249A (en) Composition for prevention or treatment of oral disease comprising lithospermic acid
KR20180055527A (en) Composition for prevention or treatment of oral disease comprising eriodictyol
KR20140002446A (en) The composite of mouth wash including the titrated extract of the unsaponifiable fraction of zea mays, which comes from an ingredient crude drug

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07870261

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07870261

Country of ref document: EP

Kind code of ref document: A2